![W. Smith](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
W. Smith
Direktor/Vorstandsmitglied bei
LYRA THERAPEUTICS, INC.
Vermögen: - $ am 30.06.2026
Profil
W.
Bradford Smith is currently Chief Financial Officer at Incendia Therapeutics, Inc. since 2024.
He serves as Independent Director at eGenesis, Inc. since 2021 and at Lyra Therapeutics, Inc. since 2019.
Formerly, Mr. Smith was Treasurer, Chief Financial & Business Officer at Homology Medicines, Inc. from 2022 to 2023.
He was Chief Financial Officer at Ocular Therapeutix, Inc. from 2014 to 2017, OmniGuide, Inc. from 2008 to 2014, NeuroMetrix, Inc. from 2005 to 2008, Synexus Compass, Inc. from 2003 to 2005, PatientKeeper, Inc. from 2000 to 2003, and Focal, Inc. from 1993 to 2000.
He held the position of Chief Financial Officer at CytoTherapuetics, Inc. and was Senior Accountant at Coopers & Lybrand LLP.
Education includes an undergraduate degree from Tufts University in 1977 and an MBA from Peter T Paul College of Business & Economics in 1981.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 14.05.2026 | 0 ( -.--% ) | - $ | 30.06.2026 |
Aktive Positionen von W. Smith
| Unternehmen | Position | Beginn |
|---|---|---|
| LYRA THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 19.11.2019 |
eGenesis, Inc.
 eGenesis, Inc. Medical/Nursing ServicesHealth Services Operates as a biotechnology company that provides organs and cells transplantation services | Direktor/Vorstandsmitglied | 09.06.2021 |
Incendia Therapeutics, Inc.
 Incendia Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel class of anti-cancer therapies | Finanzdirektor/CFO | 01.12.2024 |
Ehemalige bekannte Positionen von W. Smith
| Unternehmen | Position | Ende |
|---|---|---|
| Q32 BIO INC. | Finanzdirektor/CFO | 17.11.2023 |
| OCULAR THERAPEUTIX, INC. | Finanzdirektor/CFO | 31.03.2017 |
OmniGuide, Inc.
 OmniGuide, Inc. Medical SpecialtiesHealth Technology Develops advanced energy surgical solutions | Finanzdirektor/CFO | 01.03.2014 |
| NEUROMETRIX, INC. | Finanzdirektor/CFO | 30.06.2008 |
Synexus Compass, Inc.
 Synexus Compass, Inc. Medical/Nursing ServicesHealth Services Provides medical image analysis, subject recruitment and biochemical marker services | Finanzdirektor/CFO | 01.02.2005 |
Ausbildung von W. Smith
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
72
Beziehungen ersten Grades
14
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 14 |
|---|---|
Focal, Inc.
 Focal, Inc. Chemicals: SpecialtyProcess Industries Develops and manufactures synthetic liquid surgical sealant | Process Industries |
NeuroMetrix, Inc.
 NeuroMetrix, Inc. Medical SpecialtiesHealth Technology Designs and develops medical devices used for treatment of the neurological complications of diabetes | Health Technology |
PatientKeeper, Inc.
 PatientKeeper, Inc. Packaged SoftwareTechnology Services Provides healthcare applications for physicians | Technology Services |
Ocular Therapeutix, Inc.
 Ocular Therapeutix, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and commercializes therapies for retinal diseases & conditions of the eye | Health Technology |
Coopers & Lybrand LLP
 Coopers & Lybrand LLP Miscellaneous Commercial ServicesCommercial Services Provides accounting services | Commercial Services |
Synexus Compass, Inc.
Synexus Compass, Inc. Medical/Nursing ServicesHealth Services Provides medical image analysis, subject recruitment and biochemical marker services | Health Services |
CytoTherapuetics, Inc.
 CytoTherapuetics, Inc. Financial ConglomeratesFinance Biological Products | Finance |
Tufts University
 Tufts University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
OmniGuide, Inc.
OmniGuide, Inc. Medical SpecialtiesHealth Technology Develops advanced energy surgical solutions | Health Technology |
Lyra Therapeutics, Inc.
 Lyra Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage therapeutics company which develops and commercializes novel integrated drugs for treatment of patients with ear, nose and throat and ENT diseases | Health Technology |
Peter T Paul College of Business & Economics
 Peter T Paul College of Business & Economics Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Homology Medicines, Inc.
 Homology Medicines, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage genetic medicines company | Health Technology |
eGenesis, Inc.
eGenesis, Inc. Medical/Nursing ServicesHealth Services Operates as a biotechnology company that provides organs and cells transplantation services | Health Services |
Incendia Therapeutics, Inc.
Incendia Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel class of anti-cancer therapies | Health Technology |
Wählen Sie MarketScreener 
